← Back to Search

Local Anesthetic

Lidocaine Blocks for Regional Anesthesia (DEVILS Trial)

Durham, NC
Phase 4
Waitlist Available
Led By Brian Mendelson, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
ASA physical status 1 or 2
Age ≥ 18 years
Must not have
Systemic neuromuscular disease
Contraindications to regional anesthesia (e.g., infection, allergy, challenging sonoanatomy)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up basiline, 10, 20, 30, 45, 60, 90, 120 and 240 minutes post block.
Awards & highlights
Drug Has Already Been Approved
No Placebo-Only Group
Pivotal Trial

Summary

This trial aims to compare two nerve block techniques, the Erector Spinae Plane (ESP) block and the Intertransverse Process (ITP) block, in terms of their effectiveness in providing

See full description
Who is the study for?
This trial is for healthy adult volunteers interested in helping compare two regional anesthesia techniques for chest wall pain relief. Participants should be available for two separate procedure days and willing to undergo sensory testing and blood draws.Check my eligibility
What is being tested?
The study tests the distribution of numbness caused by two nerve block techniques, ESP and ITP, using Lidocaine. It also examines how Lidocaine is absorbed into the body with each technique. Volunteers will receive both blocks on different days.See study design
What are the potential side effects?
Potential side effects include typical reactions to local anesthetics like Lidocaine, which may involve temporary numbness or tingling at the injection site, lightheadedness, or rarely more serious effects if absorbed systemically.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am in good or mild systemic disease condition.
 show original
Select...
I am 18 years old or older.
 show original

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a disease that affects my muscles and nerves.
 show original
Select...
I cannot have regional anesthesia due to an infection, allergy, or other issues.
 show original

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~basiline, 10, 20, 30, 45, 60, 90, 120 and 240 minutes post block.
This trial's timeline: 3 weeks for screening, Varies for treatment, and basiline, 10, 20, 30, 45, 60, 90, 120 and 240 minutes post block. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Cutaneous distribution mapping
Mechanical discrimination
Temperature discrimination
Secondary study objectives
Lidocaine pharmacokinetics
Nociceptive discrimination
Pulmonary Function Test
+1 more
Other study objectives
Adverse Events

Awards & Highlights

Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intertransverse Process Block (ITP) BlockExperimental Treatment2 Interventions
Participants receive ITP Block under ultrasound guidance, with 20mL of 1.5% Lidocaine on the other visit.
Group II: Erector Spinae Plane (ESP) BlockActive Control2 Interventions
Participants receive ESP Block under ultrasound guidance, with 20mL of 1.5% Lidocaine on one visit.

Find a Location

Closest Location:Duke University Medical Center· Durham, NC

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,494 Previous Clinical Trials
5,912,399 Total Patients Enrolled
Brian Mendelson, MDPrincipal InvestigatorDuke University
~17 spots leftby Jul 2025